Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

Pentoxifylline alone and combined with triamcinolone acetonide is effective for treating localized alopecia areata, with the combination showing the highest effectiveness.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Bortezomib chemotherapy can cause temporary skin rashes.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib improved hair loss and arthritis in a lupus patient.

A rare hair follicle disorder can cause itchy, bluish-black bumps on the body.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Trichothiodystrophy causes unusual hair and developmental issues.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.